Telehealth yields modest improvements in diabetes outcomes
1. In this randomized trial, a comprehensive telehealth program produced modest but non-significant improvements in glycemic control compared with self-monitoring ...
1. In this randomized trial, a comprehensive telehealth program produced modest but non-significant improvements in glycemic control compared with self-monitoring ...
1. Amazon has expanded its generative artificial intelligence assistant to all United States users, enabling integration with electronic health information ...
Roche and NVIDIA deploy the pharmaceutical industry's largest AI factory A major leap in computational drug development has emerged with ...
1. In this cross-sectional study, 16.4% of Medicare beneficiaries had at least one telehealth visit between 2021 and 2023, with ...
Key Points: 1. Lilly sues four telehealth firms for unauthorized compounding of Mounjaro and Zepbound. 2. GLP 1 drugs remain ...
Drugmakers Increase Prices on Over 250 Medications Pharmaceutical companies have raised prices on over 250 branded medications in the U.S., ...
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
1. A randomized trial for a blood pressure (BP) self-management program, involving 6 months of telehealth coaching for hypertensive young ...
1. In a randomized clinical trial, internet-delivered parent-child interaction therapy (iPCIT) was associated with improvements in externalizing behaviors, positive parenting skills, ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.